EUVIMEDEUVIMED entdecken
Open Access

Complementary and Alternative Medicine Use in Patients With Cancer and Immigration Background

Alex Wu, Yunhong Wu, Vijaya Natarajan, Prabhsimranjot Singh, Waseem Cheema iD, Rukhsana Hossain, Christine Liu, Yocasta Mejia, Myoe Htet Htet Oo, Bina Valenzano, Yiqing Xu iD

JCO Global Oncology · 2023

DOI: 10.1200/go.22.00303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Global Oncology, 2023. Verfasst von Alex Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Department of Medicine, Maimonides Medical Center, Brooklyn, NY. Hauptthemen laut MEDLINE: Complementary Therapies, Neoplasms, Emigration and Immigration. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Studies have shown that patients with cancer are more likely to use complementary and alternative medicine (CAM) than noncancer patients for symptom relief and hope. We aimed to evaluate factors of race, ethnic groups, and immigration status in attitude of patients with cancer in seeking out CAM. PATIENTS AND METHODS This is a prospective questionnaire study where information on demographics, cancer information, race/ethnicity, immigration duration, and psychosocial factors was correlated with the CAM use in a community cancer center located in the borough of Brooklyn, at New York City. RESULTS Among 658 patients, the prevalence of CAM use was 66.11%. CAM use was 71.98% in females and 54.34% in males ( P = .113 × 10 −4 ). Patients of African descent had higher CAM use (72.73%) than the White patients (63.53%; P = .0371). There was no difference of CAM use between the US born (68.77%) and the immigrants (63.98%, P = .199) as a whole; however, comparing with the US born (66.50%), Asian-born immigrants had lower CAM use (53.77%, P = .0161), whereas Latin-American born had a numerical trend toward higher CAM use (74.83%, P = .0608). The number of years of living in the United States was not associated with more CAM use. Prayer and spirituality was the most common CAM subtype used (25.91%). There was no difference in CAM use in the respective non-White ethnic groups whether they were US born or non-US born. CONCLUSION In this cohort of patients with cancer enriched with immigration background, CAM use was the highest in African American patients. The use of CAM in the non-White patients was associated with their ethnic background, regardless whether they were US born or not. Cultural roots appeared to be a strong influencing factor for the usage of CAM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Complementary TherapiesNeoplasmsEmigration and ImmigrationCentral American PeopleAfrican PeopleTime FactorsEthnicityUnited StatesAsianHumansBlack or African AmericanMaleFemaleHispanic or LatinoProspective StudiesSouth American PeopleNew York CityWhiteHopeBlack People

Autor:innen und Institutionen

  • Division of Hematology/Oncology, Department of Medicine, Maimonides Medical Center, Brooklyn, NY.
  • Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA.

ORCID-Profile: Waseem Cheema, Yiqing Xu

Zitieren

APA

Wu, A., Wu, Y., Natarajan, V., Singh, P., Cheema, W., Hossain, R., Liu, C., Mejia, Y., Oo, M. H. H., Valenzano, B., & Xu, Y. (2023). Complementary and Alternative Medicine Use in Patients With Cancer and Immigration Background. JCO Global Oncology. https://doi.org/10.1200/go.22.00303

Vancouver

Wu A, Wu Y, Natarajan V, Singh P, Cheema W, Hossain R, et al. Complementary and Alternative Medicine Use in Patients With Cancer and Immigration Background. JCO Global Oncology. 2023. doi:10.1200/go.22.00303

BibTeX
@article{Wu2023,
  author = {Wu, Alex and Wu, Yunhong and Natarajan, Vijaya and Singh, Prabhsimranjot and Cheema, Waseem and Hossain, Rukhsana and Liu, Christine and Mejia, Yocasta and Oo, Myoe Htet Htet and Valenzano, Bina and Xu, Yiqing},
  title = {Complementary and Alternative Medicine Use in Patients With Cancer and Immigration Background},
  journal = {JCO Global Oncology},
  year = {2023},
  doi = {10.1200/go.22.00303}
}
Kostenlos starten →